Atea Pharmaceuticals, Inc. - AVIR
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Oct 06, 2026 | SCHEDULE 13G | TANG CAPITAL MANAGEMENT, LLC | 6.0% | 4,814,700 | View |
| Oct 06, 2026 | SCHEDULE 13G | KEVIN TANG | 6.0% | 4,814,700 | View |
| Oct 06, 2026 | SCHEDULE 13G | TANG CAPITAL PARTNERS, LP | 3.1% | 2,488,519 | View |
| Oct 06, 2026 | SCHEDULE 13G | TANG CAPITAL PARTNERS INTERNATIONAL, LP | 2.1% | 1,665,077 | View |
| Oct 06, 2026 | SCHEDULE 13G | TANG CAPITAL PARTNERS III, INC | 0.8% | 661,104 | View |
| Oct 06, 2026 | SCHEDULE 13G | TANG CAPITAL PARTNERS IV, INC | 0.0% | 0 | View |
| May 06, 2026 | SCHEDULE 13G/A | FMR LLC | 15.0% | 11,950,772 | View |
| May 06, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 15.0% | 11,950,772 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.